Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/EBIT

    Back to All Ratios
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 40.6033.6659.657.143.15

What is the latest EV/EBIT ratio of PIRAMAL PHARMA ?

The latest EV/EBIT ratio of PIRAMAL PHARMA is 40.60 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202540.60
Mar202433.66
Mar202359.65
Mar20227.14
Mar20213.15

How is EV/EBIT of PIRAMAL PHARMA Trending?

Years EV/EBIT % Change
Mar2025 40.6
20.62
Mar2024 33.66
-43.57
Mar2023 59.65
735.43
Mar2022 7.14
126.67
Mar2021 3.15 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/EBIT ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,599.1 Cr 3.2% -4.3% -32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,417.9 Cr 0.9% -7.8% -12.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.2%

-4.3%

-32.5%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses